Pembrolizumab for melanoma- safety profile and future trends

被引：7
作者：
Daud, Adil [1 ]
Nandoskar, Prachi [1 ]
机构：
[1] UCSF Helen Diller Comprehens Canc Ctr, Melanoma Clin Res, Dept Med Hematol Oncol, 1600 Divisadero St,Box 1297, San Francisco, CA 94115 USA
来源：
EXPERT OPINION ON DRUG SAFETY | 2016年 / 15卷 / 06期
关键词：
Melanoma; pembrolizumab; safety; cancer immunotherapy; PD-1; SOLID TUMORS; PATIENTS PTS; IPILIMUMAB; MK-3475; CHEMOTHERAPY; ASSOCIATION; KEYNOTE-002; THERAPY; CANCER; PEMBRO;
D O I：
10.1080/14740338.2016.1175430
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：727 / 729
页数：3
相关论文
共 50 条
[31]   Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma [J].
Robert, Caroline ;
Hwu, Wen-Jen ;
Hamid, Omid ;
Ribas, Antoni ;
Weber, Jeffrey S. ;
Daud, Adil, I ;
Hodi, F. Stephen ;
Wolchok, Jedd D. ;
Mitchell , Tara C. ;
Hersey, Peter ;
Dronca, Roxana ;
Joseph, Richard W. ;
Boutros, Celine ;
Min, Le ;
Long, Georgina, V ;
Schachter, Jacob ;
Puzanov, Igor ;
Dummer, Reinhard ;
Lin, Jianxin ;
Ibrahim, Nageatte ;
Diede, Scott J. ;
Carlino, Matteo S. ;
Joshua, Anthony M. .
EUROPEAN JOURNAL OF CANCER, 2021, 144 :182-191
[32]   PD-1 inhibition and treatment of advanced melanoma-role of pembrolizumab [J].
Jazirehi, Ali R. ;
Lim, Alexandra ;
Dinh, Tam .
AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (10) :2117-2128
[33]   Pembrolizumab in the treatment of advanced/metastatic melanoma: a single-center institution experience [J].
Cimminiello, Carolina ;
Indini, Alice ;
Di Guardo, Lorenza ;
Prisciandaro, Michele ;
Randon, Giovanni ;
Tolomio, Elena ;
De Braud, Filippo ;
Del Vecchio, Michele .
MELANOMA RESEARCH, 2019, 29 (03) :289-294
[34]   Cutaneous lupus associated with pembrolizumab therapy for advanced melanoma: a report of three cases [J].
Blakeway, Elizabeth A. ;
Elshimy, Noha ;
Muinonen-Martin, Andrew ;
Marples, Maria ;
Mathew, Bipin ;
Mitra, Angana .
MELANOMA RESEARCH, 2019, 29 (03) :338-341
[35]   Pediatric Melanoma- Diagnosis, Management, and Anticipated Outcomes [J].
Aldrink, Jennifer H. ;
Polites, Stephanie F. ;
Austin, Mary .
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 30 (02) :373-388
[36]   Cutaneous Melanoma in Alpine Population: Incidence Trends and Clinicopathological Profile [J].
Buja, Alessandra ;
Rugge, Massimo ;
De Luca, Giuseppe ;
Bovo, Emanuela ;
Zorzi, Manuel ;
De Toni, Chiara ;
Cozzolino, Claudia ;
Vecchiato, Antonella ;
Del Fiore, Paolo ;
Spina, Romina ;
Cinquetti, Sandro ;
Baldo, Vincenzo ;
Rossi, Carlo Riccardo ;
Mocellin, Simone .
CURRENT ONCOLOGY, 2022, 29 (03) :2165-2173
[37]   The safety of nivolumab for the treatment of metastatic melanoma [J].
O'Reilly, Aine ;
Larkin, James .
EXPERT OPINION ON DRUG SAFETY, 2017, 16 (08) :955-961
[38]   Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma [J].
Karydis, Ioannis ;
Chan, Pui Ying ;
Wheater, Matthew ;
Arriola, Edurne ;
Szlosarek, Peter W. ;
Ottensmeier, Christian H. .
ONCOIMMUNOLOGY, 2016, 5 (05)
[39]   Pembrolizumab: A Review in Advanced Melanoma [J].
Deeks, Emma D. .
DRUGS, 2016, 76 (03) :375-386
[40]   Pembrolizumab in the management of metastatic melanoma [J].
Spain, Lavinia ;
Younger, Eugenie ;
Hatipoglu, Emine ;
Larkin, James .
MELANOMA MANAGEMENT, 2015, 2 (04) :315-325
12345